Le Lézard
Classified in: Health
Subjects: LAW, PLW

Medit wins four consecutive patent lawsuits against 3Shape

SEOUL, South Korea, Oct. 7, 2022 /PRNewswire/ -- Medit Corp. ("Medit"), a global provider of 3D scanning solutions, has successfully defended against four separate patent infringement actions filed in Germany by a Danish competitor, 3Shape A/S ("3Shape").  Over the past 3 years, 3Shape has aggressively pursued patent infringement actions against Medit based on four patents (EP 2,568,870; EP 2,400,919; EP 2,732,434; EP 3,401,876). However, all four patent lawsuits have now been concluded in Medit's favor by German courts. Moreover, 1 of the 4 patents were invalidated by German courts.

Medit wins four consecutive patent lawsuits against 3Shape

"We are delighted to find that the court confirmed these cases were without merit and also it was an attempt by the competitor to protect its preemptive position. We hope that this result helps discourage reckless legal disputes in the future. We see this as a victory for our customers and partners, and ultimately all those interested in digital dentistry. These rulings offer digital dentistry market a greater clarity and much needed security.  Medit will continue to bring the best technology for the benefit of our customers and the patients." <GB Ko, CEO> 

Photo - https://mma.prnewswire.com/media/1915266/IOS_family_3_rv.jpg

Logo - https://mma.prnewswire.com/media/1798058/Logo_MEDIT_Logo.jpg 

These press releases may also interest you

at 11:40
In May, organ donation and organ transplants in New England attained a new monthly record high. New England Donor Services (NEDS), the federally-designated Organ Procurement Organization responsible for the recovery of organs and tissues in the six...

at 11:34
The Netherlands is a prime location for biotech companies that bring forth an open-minded, innovative and inclusive approach to novel challenges in life sciences and health. Companies that invest in Holland are innovating for the benefit of patients...

at 11:30
Kite, a Gilead Company , today announces detailed results from the overall survival (OS) analysis of the landmark Phase 3 ZUMA-7 study of Yescarta® (axicabtagene ciloleucel [axi-cel]) CAR T-cell therapy compared with historical standard of care (SOC)...

at 11:20
The "Allogeneic Cell Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Stem Cell, Non-stem Cell), By Therapeutic Area (Hematological Disorders, Dermatological Disorders), By Region, And Segment Forecasts, 2023 - 2030" report has...

at 11:15
GoldStar Medical Instruments has achieved a total web-based solution for inventory control, traceability, accounting and quality management with their implementation of Cetec ERP; a complete web-based ERP business platform. GoldStar Medical...

at 11:12
The Doctors Company, the nation's largest physician-owned medical malpractice insurer, is pleased to announce the appointment of Christa Steele, MBA, to its Board of Governors. Ms. Steele is a financial and governance executive with decades of...

News published on and distributed by: